iMeds.se

Vectatone

Document: Vectatone cream ENG PL change

Package leaflet: information for the user


Vectatone 1% cream


penciclovir


Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you.

If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

You must talk to a doctor if your symptoms worsen or do not improve within 4 days.


What is in this leaflet:

1. What Vectatone is and what it is used for

2. What you need to know before you use Vectatone

3. How to use Vectatone

4. Possible side effects

5. How to store Vectatone

6. Contents of the pack and other information



1. What Vectatone is and what it is used for


Vectatone is a beige to light brown cream that is used for the treatment of cold sores (herpes labialis) caused by herpes simplex. The cream should be applied as soon as possible when symptoms appear, when the lips begin to “tingle” and/or when bumps/blisters start to form. It should not be applied once scabs have formed. You must talk to a doctor if your symptoms worsen or do not improve within 4 days.


Vectatone inhibits the ability of the herpes simplex virus to multiply. The time needed for healing and the duration of pain and visible signs of the virus are shortened by up to 24 hours.


2. What you need to know before you use Vectatone


Do not use Vectatone


Warnings and precations

Talk to your doctor or pharmacist before using Vectatone:


The cream must not be applied in or near the eyes, genitals or mucous membranes (e.g. mouth or nose).


Vectatone should only be used on cold sores on the lips or around the mouth.


Other medicines and Vectatone

It is unlikely that the effect of the treatment will be affected if Vectatone cream is used at the same time as other medicines.

Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines.


Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using his medicine.


Pregnancy

Experience of use during pregnancy is limited.


Breast-feeding

It is not known whether the active ingredient is passes into mother's milk.


Driving and using machines

Vectatone does not affect your ability to operate a vehicle.


Vectatone contains cetostearyl alcohol and propylene glycol

Vectatone contains cetostearyl alcohol and propylene glycol, which could cause skin irritation or local skin reactions (e.g. contact dermatitis).


3. How to use Vectatone


Always use this medicineexactlyas described in this leaflet or as your doctor has told you. Check with your doctor or pharmacist if you are not sure.


For adults and children over 12 years of age

Use as early as possible at the first signs of infection, e.g. itching and tingling sensation. Some people do not notice these symptoms. However, Vectatone cream has an effect and can still be applied when the first bumps/blisters have started to form.



1. Always wash your hands before and after applying the cream.


2. Squeeze a small amount of cream onto the tip of your finger.


3. Apply the cream every two hours throughout the day for 4 days.


If the treatment time is at the same time as a meal, apply the cream after you have eaten.


It may take some time before the cream begins to work. Continue using the cream even if the sore does not feel better immediately. Use the cream for 4 days unless you have received other instructions from your doctor.


Use in children
Vectatone Cream must not be used on children under 12 years of age.


If you use more Vectatone than you should

It is not likely to be any serious problems if you at once, have used a large amount of cream on your skin, although some irritation of the skin may occur.


The cream is not harmful if swallowed, but it may cause some irritation in the mouth. No special treatment is necessary.


If a child has accidentially used the medicine in an inapproporiate way please contact your doctor or hospital.


4. Possible side effects


Like all medicines, this medicine can cause side effects, although not everybody gets them.


The most common side effects (may affect up to 1 in 10 people) are reactions at the area of application, e.g. burning sensation, pain or numbness.


Side effects that have been reported and occur in an unknown number of users are hypersensitivity, nettle rash and allergic dermatitis (e.g. rash, itching, blisters and swelling).


If any of the side effects gets serious, or if you notice any side effect not listed in this leaflet, please tell your doctor or pharmacist.


Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist.This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system (see details below). By reporting side effects you can help provide more information on the safety of this medicine.

[To be completed nationally]


5. How to store Vectatone


Keep this medicine out of the sight and reach of children.


Do not store above 30˚C. Do not freeze.


Do not use this medicine after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month.


Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.


6. Contents of the pack and other information


What Vectatone contains


What Vectatone looks like and contents of the pack

Vectatone is a smooth, beige to light brown cream.

Package sizes: 2 g and 5 g tube.


Not all package sizes may be marketed.


Marketing Authorisation Holder and Manufacturer


Marketingauthorization holder: [To be completed nationally]

Manufacturer: Omega Pharma International NV, Venecoweg 26, B-9810 Nazareth, Belgium


This leaflet was last revised in 28 April 2016

3